Literature DB >> 10216140

Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high-density lipoproteins to bile: studies using the perfused rat liver.

S J Robins1, J M Fasulo.   

Abstract

Cholesterol is principally excreted from the body in bile as unesterified cholesterol (UC). Using the unesterified plant sterol, sitostanol (SIT), as a nonexchangeable analog for UC, we have found that high-density lipoproteins (HDL), but not low-density lipoproteins, provide a vehicle for the direct delivery of cholesterol to bile. To determine the mechanism for preferential cholesterol transport from HDL to bile, isolated rat livers were perfused with a reconstituted HDL, made with radiolabeled unesterified SIT, UC, and cholesteryl esters (CE). Total biliary sterol secretion was independent of the concentration of HDL added to perfusions, but with increasing HDL-SIT perfused, the proportion of SIT to cholesterol in bile was linearly increased. Biliary SIT secretion was rapid (detected within 2 to 4 minutes after reconstituted HDL was added to perfusions) and was dependent on the immediate presence of SIT in the perfusate, but independent of the amount of SIT that had accumulated in the liver. The ratio of SIT to UC was seven- to ninefold greater in bile than in the liver, consistent with preferential mobilization of membrane sterols delivered from HDL. Although radiolabeled UC as well as SIT was taken up from HDL by the liver and secreted in bile, net UC uptake could not be quantitated because of both UC exchange and a sizable enrichment of HDL with UC mass that approximated the SIT removed during the passage of HDL through the liver. These results are consistent with sterol transport to bile from HDL by a direct plasma membrane pathway and by a mechanism that appears to involve substitution of unesterified (exogenous) sterol from HDL for plasma membrane UC during transport. By this process, HDL can promote reverse cholesterol transport from peripheral tissues to bile, even without an increase in biliary cholesterol secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216140     DOI: 10.1002/hep.510290518

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Cooperation between hepatic cholesteryl ester hydrolase and scavenger receptor BI for hydrolysis of HDL-CE.

Authors:  Quan Yuan; Jinghua Bie; Jing Wang; Siddhartha S Ghosh; Shobha Ghosh
Journal:  J Lipid Res       Date:  2013-08-29       Impact factor: 5.922

2.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

Authors:  YuZhen Zhang; Jaqueline R Da Silva; Muredach Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein.

Authors:  Carlos L J Vrins; Roelof Ottenhoff; Karin van den Oever; Dirk R de Waart; J Kar Kruyt; Ying Zhao; Theo J C van Berkel; Louis M Havekes; Johannes M Aerts; Miranda van Eck; Patrick C N Rensen; Albert K Groen
Journal:  J Lipid Res       Date:  2012-07-16       Impact factor: 5.922

4.  Intracellular cholesterol-binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes.

Authors:  Stephen M Storey; Avery L McIntosh; Huan Huang; Kerstin K Landrock; Gregory G Martin; Danilo Landrock; H Ross Payne; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

5.  Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes.

Authors:  Stephen M Storey; Barbara P Atshaves; Avery L McIntosh; Kerstin K Landrock; Gregory G Martin; Huan Huang; H Ross Payne; Jeffery D Johnson; Ronald D Macfarlane; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-15       Impact factor: 4.052

Review 6.  Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.

Authors:  Helen H Wang; Piero Portincasa; Ornella de Bari; Kristina J Liu; Gabriella Garruti; Brent A Neuschwander-Tetri; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-02-19       Impact factor: 4.686

7.  Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Philip N Howles; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

8.  Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation.

Authors:  Devon Klipsic; Danilo Landrock; Gregory G Martin; Avery L McIntosh; Kerstin K Landrock; John T Mackie; Friedhelm Schroeder; Ann B Kier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-25       Impact factor: 4.052

9.  Tofu and fish oil independently modulate serum lipid profiles in rats: Analyses of 10 class lipoprotein profiles and the global hepatic transcriptome.

Authors:  Yoko Takahashi; Tomokazu Konishi; Kohji Yamaki
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

10.  Lipoprotein Particles Interact with Membranes and Transfer Their Cargo without Receptors.

Authors:  Birgit Plochberger; Taras Sych; Florian Weber; Jiri Novacek; Markus Axmann; Herbert Stangl; Erdinc Sezgin
Journal:  Biochemistry       Date:  2020-11-04       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.